A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Alitretinoin (BAL4079) in the Treatment of Severe Chronic Hand Eczema Refractory to Potent Topical Corticosteroid Therapy

Authors
Category Primary study
JournalJOURNAL OF DRUGS IN DERMATOLOGY
Year 2014
This article has no abstract
Epistemonikos ID: 9af67f42bc40f1726152f815eb409d058ce7b776
First added on: Nov 18, 2025